Table of Contents
Volume 2 | Supplement 2
Publication Date: May 2001- Abstract
- No Access
- Pay-Per View
- Full Text
- Add to Cart
Contributions | ||
S4-S8 |
Irinotecan in Small-Cell Lung Cancer: Current Data Karen Kelly |
|
S9-S13 |
Irinotecan: Future Directions in Small-Cell Lung Cancer Alan Sandler |
|
S14-S19 |
Irinotecan and Platinums in the Treatment of Non–Small-Cell Lung Cancer Paul A. Bunn, Jr |
|
S20-S25 |
Irinotecan and Taxane Combinations for Non–Small-Cell Lung Cancer John R. Murren, Marianne Davies |
|
S26-S33 |
Irinotecan (CPT-11) in Triplet Combinations in Patients with Advanced Non–Small-Cell Lung Cancer: A Review and Report of a Phase I/II Trial Mark A. Socinski, Alan B. Sandler, Langdon L. Miller, Paula K. Locker, Cristy K. Hanover, Gary L. Elfring, Valerie K. Israel, Nicoletta Pirotta, Ronald B. Natale |
|
S34-S40 |
Topoisomerase I Inhibitors in the Combined Modality Therapy of Lung Cancer Hak Choy, Jae-Sung Kim, Hongryull Pyo, Rob MacRae |
|